DEVELOPING AND CLINICALLY TRANSLATING TECHNOLOGIES AND BIOLOGICAL KNOWLEDGE DESIGNED TO HELP ANTICIPATE AND TREAT THERAPY RESISTANCE IN GBM PATIENTS, PRIOR TO THE APPEARANCE OF THAT RESISTANCE.

PIs: Timothy Cloughesy, M.D.
Director and Professor, Neuro-Oncology Program
University of California Los Angeles (UCLA)

James R. Heath, Ph.D.
Elizabeth W. Gilloon Professor of Chemistry
California Institute of Technology

Paul S. Mischel, M.D.
Member and Head Professor, Laboratory of Molecular Pathology
Ludwig Institute for Cancer Research
University of California San Diego (UCSD)

Close Menu